Girolamo Todd C

CLO, SVP of Corp DevCALADRIUS BIOSCIENCES, INC. (CLBS) · full profile →Form 4 · filed Jan 12, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
3 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 11, 2022Tax withholding(F)5K$0.87$4K166K
Jan 10, 2022Grant(A)129K$0188K
Jan 10, 2022Tax withholding(F)17K$0.92$16K170K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 10, 2022Grant(A)65K$065K

Transaction Codes

F
Shares withheld for taxes
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001891257-22-000002) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Ask your agent about CLBS insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001891257-22-000002"
Ask your agent
Use Arkolith to summarize insider buying and selling at CALADRIUS BIOSCIENCES, INC.
over the last 90 days and cite the filings.